MG217 Baby Eczema
MG217 Baby Eczema is an FDA drug label for the active ingredient COLLOIDAL OATMEAL manufactured by Wisconsin Pharmacal Company administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20171128.
Generic: COLLOIDAL OATMEAL
Manufacturer: Wisconsin Pharmacal Company
Product Type: HUMAN OTC DRUG
Route: TOPICAL
Dosage Form:
NDC: 68093-5105
Application: part347
Effective: 20171128
Active Ingredients: Active Ingredient Colloidal Oatmeal (Oat Kernel Flour) 2%
Indications & Usage
Uses Temporarily protects and helps relieve minor skin irritation and itching due to eczema rash dermatitis
Dosage & Administration
Directions Apply as needed, especially after bathing. Massage thoroughly into skin as colloidal oatmeal is slow to absorb.
Contraindications
Not available.
Warnings
For external use only
Adverse Reactions
Not available.
More from same ingredient
Babo Botanicals Sensitive Baby Healing
Babo Botanicals, Inc.
Badger After-BUG Balm
W.S. Badger Company, Inc.
Cetaphil Baby Eczema Soothing
Galderma Laboratories, L.P.
Eczema Care Moisturizing 3 oz.
Rejoice International Inc.
EczemaHoneyBodyLotion
Allure Labs
First Aid Beauty FAB Ultra Repair Skin Protectant Candy Cane
The Procter & Gamble Manufacturing Company
MG217 Eczema Face
Wisconsin Pharmacal Company